MCHX

MARCHEX INC
5 filings tracked
technologycloud computingMICRO (<$300M)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Marchex is demonstrating a decisive shift toward operational efficiency, characterized by a dramatic reduction in its cost structure. The company reported a 32% plunge in General and Administrative expenses, driven by a strategic reorganization that slashed personnel costs.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The narrative of an operational turnaround is challenged by deteriorating core margins and precarious liquidity.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every MCHX filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing reveals a company at a crossroads, balancing aggressive cost-cutting against structural revenue headwinds. Marchex has successfully lean-out its operations, significantly reducing G&A and cash burn, but it has yet to prove that the 'Engage Platform' migration can reverse the current revenue decline. The tension between a shrinking cost base and rising cost-of-revenue percentages suggests a struggle to maintain pricing power or efficiency in service delivery. Investors are now weighing the potential of the Archenia acquisition against the risks of increased leverage and customer concentration. While the reduction in operating losses is a positive signal, the reliance on a few key customers and the use of convertible debt to fund growth create a volatile risk profile. The overall impact of the filing is a shift in focus from survival to the execution of a high-stakes growth strategy funded by debt.

Selected Quarter

Core Takeaway

Marchex has successfully lowered its break-even point through aggressive cost-cutting, but must now prove it can grow revenue without increasing its cost-of-service ratio.

Investor Lens

The trade-off is between the proven ability to cut costs and the unproven ability to re-accelerate revenue growth via the Engage Platform.

Watch Next

Closing of the Archenia acquisition in Q3 2026 and the subsequent impact on revenue run rates.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.22Q1 '26 (10-K)-0.20Q2 '26 (8-K)-0.05Q2 '26 (10-Q)

Signal Timeline

8 of 18
Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 14

Revenue decreased 7% year-over-year due to platform migration offsets.

earnings miss
60%
bullishMay 14

G&A expenses plummeted 32% through strategic reorganization.

margin expansion
80%
neutralMay 14

Signed agreement to acquire Archenia for $10M in convertible notes.

acquisition
50%
bearishMay 14

Potential dilution from convertible notes associated with Archenia acquisition.

capital raise
40%
bearishMay 14

Revenue decreased 7% year-over-year due to platform migration offsets.

earnings miss
60%
bullishMay 14

G&A expenses plummeted 32% through strategic reorganization.

margin expansion
80%
neutralMay 14

Signed agreement to acquire Archenia for $10M in convertible notes.

acquisition
50%
bearishMay 14

Potential dilution from convertible notes associated with Archenia acquisition.

capital raise
40%

Filing History

10-QMay 14, 2026
Expand Sequence

The Q1 2026 filing reveals a company at a crossroads, balancing aggressive cost-cutting against structural revenue headwinds. Marchex has successfully lean-out its operations, significantly reducing G&A and cash burn, but it has yet to prove that the 'Engage Platform' migration can reverse the current revenue decline. The tension between a shrinking cost base and rising cost-of-revenue percentages suggests a struggle to maintain pricing power or efficiency in service delivery. Investors are now weighing the potential of the Archenia acquisition against the risks of increased leverage and customer concentration. While the reduction in operating losses is a positive signal, the reliance on a few key customers and the use of convertible debt to fund growth create a volatile risk profile. The overall impact of the filing is a shift in focus from survival to the execution of a high-stakes growth strategy funded by debt.

8-KMay 13, 2026
Expand Sequence

The Q1 2026 filing places Marchex at a crossroads between a successful AI transformation and a liquidity crisis. While the company claims a shift toward high-margin intelligence tools, the tension between non-GAAP optimism and GAAP reality creates a polarized outlook. Investors must now determine if the reported operational improvements are genuine catalysts for a valuation re-rating or merely window-dressing for a company struggling with fundamental financial instability.

10-KMar 26, 2026
Expand Sequence

The 10-K reveals a company at a critical crossroads, attempting to trade legacy call-tracking revenue for a high-growth AI intelligence narrative. The tension lies between the promising technological pivot toward generative AI and a deteriorating financial baseline. While the reduction in R&D spend and the push into API-led distribution are positive strategic moves, they are currently overshadowed by declining revenues and a shrinking cash pile. Investors are essentially betting on whether Marchex's AI-driven product roadmap can accelerate revenue growth fast enough to offset its current burn rate. The upcoming acquisition of Archenia and the execution of the new product suite will be the primary catalysts. Until the company demonstrates a reversal in revenue decline and a stabilization of its cash position, the bull case remains speculative, contingent on the successful monetization of its conversational data moat.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.